BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35876924)

  • 21. Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance.
    Fujiwara Y; Tsunedomi R; Yoshimura K; Matsukuma S; Fujiwara N; Nishiyama M; Kanekiyo S; Matsui H; Shindo Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    Pancreas; 2021 Mar; 50(3):405-413. PubMed ID: 33835973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer stem-like cells can promote metastasis by activating platelets and down-regulating antitumor activity of natural killer cells.
    Wang S; Zhang Y; Cong W; Liu J; Zhang Y; Fan H; Xu Y; Lin H
    J Tradit Chin Med; 2016 Aug; 36(4):530-7. PubMed ID: 28459521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.
    Cao L; Zhou Y; Zhai B; Liao J; Xu W; Zhang R; Li J; Zhang Y; Chen L; Qian H; Wu M; Yin Z
    BMC Gastroenterol; 2011 Jun; 11():71. PubMed ID: 21669008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.
    Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Kimura R; Miyagi T; Mochizuki K; Sasaki Y; Hayashi N
    Int J Cancer; 2003 Apr; 104(3):354-61. PubMed ID: 12569559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells.
    Qiu MJ; He XX; Bi NR; Wang MM; Xiong ZF; Yang SL
    Clin Chim Acta; 2018 Oct; 485():103-105. PubMed ID: 29940148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
    Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
    J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy.
    Xu X; Xing B; Hu M; Xu Z; Xie Y; Dai G; Gu J; Wang Y; Zhang Z
    Cytotherapy; 2010 Apr; 12(2):190-200. PubMed ID: 19929456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.
    Chung YM; Khan PP; Wang H; Tsai WB; Qiao Y; Yu B; Larrick JW; Hu MC
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoma SK Hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity.
    Eun JR; Jung YJ; Zhang Y; Zhang Y; Tschudy-Seney B; Ramsamooj R; Wan YJ; Theise ND; Zern MA; Duan Y
    PLoS One; 2014; 9(10):e110744. PubMed ID: 25338121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells.
    Ke M; Zhang Z; Xu B; Zhao S; Ding Y; Wu X; Wu R; Lv Y; Dong J
    Int Immunopharmacol; 2019 Oct; 75():105824. PubMed ID: 31437792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel small-form NEDD4 regulates cell invasiveness and apoptosis to promote tumor metastasis.
    Liao CJ; Chi HC; Tsai CY; Chen CD; Wu SM; Tseng YH; Lin YH; Chung IH; Chen CY; Lin SL; Huang SF; Huang YH; Lin KH
    Oncotarget; 2015 Apr; 6(11):9341-54. PubMed ID: 25823820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition.
    Yang L; Shen M; Xu LJ; Yang X; Tsai Y; Keng PC; Chen Y; Lee SO
    Sci Rep; 2017 Aug; 7(1):7958. PubMed ID: 28801607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
    Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
    Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 36. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
    Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
    Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
    [No Abstract]   [Full Text] [Related]  

  • 37. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
    Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
    Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
    Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.
    Tao Z; Ruan H; Sun L; Kuang D; Song Y; Wang Q; Wang T; Hao Y; Chen K
    Cancer Immunol Res; 2019 Jul; 7(7):1135-1147. PubMed ID: 31113805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.